NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
The iRR6 model refines risk stratification for intermediate-1 myelofibrosis patients, incorporating ruxolitinib dosing, spleen reduction, and transfusion needs. Validation in an external cohort ...
The multi-modal approach leverages additional information from the patient's tumor sample, using Natera's AI models trained on long-term molecular and clinical outcomes from Natera's proprietary ...
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...
A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant ...
Retinal artificial intelligence screening was associated with improved CVD risk classification in hypertensive retinopathy.
A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback